While no change was seen in PPARγ protein levels in the patient serum or in the in vivo and in vitro models, the RNA sequence analysis of OA-treated cells suggested that the PPAR signaling pathway was involved in the hepatic steatosis process. This evidence concerns the gene PPARA and Hepatic steatosis.